Summary
The structural features of HLA-DQ alleles which are susceptible and resistant to insulin-dependent diabetes mellitus (IDDM) have been examined using a model of their three-dimensional structure obtained by energy minimisation, based on the published structure of HLA-DR1. The model shows DQ molecules to have an overall shape nearly identical to that of DR molecules, but with significant differences in the fine structure: 1) the antigen-binding groove of DQ molecules has a polymorphic first pocket; this pocket can be either amphiphilic or hydrophilic, 2) The Β49–56 dimerisation domain of DQ is polymorphic: hydrophobic, or amphiphilic, or hydrophilic and positively charged, leading to spontaneous or T-cell receptor-induced homodimer formation, or difficulty of the formation of such dimers, respectively; 3) a prominent Arg-Gly-Asp loop is formed by some DQ alleles (Β167–169) and probably functions in cell adhesion. There are also small differences in the residues and sequences implicated in CD4 binding (mostly in DQΒ134–148) but the significance of these differences cannot be evaluated at present. All seven DQ alleles which confer susceptibility to IDDM posses a hydrophilic first pocket in the antigen-binding groove, a hydrophobic or amphiphilic Β49–56 dimerisation patch that allows for spontaneous or T-cell receptor-induced dimerisation, and the Arg-Gly-Asp loop. By contrast, in the protective alleles at least one of these three features is absent. This segregation of phenotypes according to susceptibility or resistance can well explain the model of tighter autoantigen binding by the protective alleles compared to the susceptible alleles, previously proposed for the pathogenesis of IDDM.
Article PDF
Similar content being viewed by others
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- HLA:
-
human leukocyte antigen
- MHC:
-
major histocompatibility complex
- Arg-Gly-Asp:
-
Arginine-Glycine-Aspartate
References
Todd JA, Acha-Orbea H, Bell JI et al. (1988) A molecular basis for MHC Class II-associated autoimmunity. Science 240: 1003–1009
Platz P, Jakobsen BK, Morling N et al. (1981) HLA-D and -DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
Owerbach D, Lernmark A, Platz P et al. (1983) HLA-DR beta-chain DNA endonuclease fragments differ between healthy and insulin dependent diabetic individuals. Nature 303: 815–817
Cohen-Haguenauer O, Robbins E, Busson M et al. (1985) A systematic study of HLA class II-B DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Nat Acad Sci USA 82: 3335–3339
Erlich HA, Bugawan T, Scharf S, Nepom GT, Tait B, Griffith R (1990) HLA-DQB sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96–103
Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J (1992) Dose effect of cis and trans encoded HLA-DQαΒ heterodimers in type 1 diabetes susceptibility. Diabetes 41: 378–384
Todd JA, Bell JI, McDevitt HO (1987) HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 559–604
Khalil I, d'Auriol, L, Gobet M et al. (1990) A combination of HLA-DQB Asp57-negative and HLA-DQα Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85: 1315–1319
RØnningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E (1989) The aminoacid position 57 of HLA-DQB chain and susceptibility to develop insulin-dependent diabetes mellitus (type 1 diabetes). Human Immunol 26: 215–225
Thorsby E, RØnningen KS (1993) Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 371–377
Davies JL, Kawaguchi Y, Bennett ST et al. (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130–136
Nepom GT (1990) A unified hypothesis for the complex genetics of HLA associations with type 1 diabetes. Diabetes 39: 1153–1157
Altman DM, Sansom D, Marsh SGE (1991) What is the basis of HLA-DQ associations with autoimmune disease? Immunol Today 12: 267–270
Gillis S (1989) T cell-derived lymphokines. In: Paul WE (ed) Fundamental Immunology, 2nd edn. Raven Press, New York, pp 621–638
Fossum B, Gedde-Dahl III T, Hansen T, Eriksen JA, Thorsby E, Gaudernack G (1993) Overlapping epitopes encompassing a point mutation (12 Gly → Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells. Eur J Immunol 23: 2687–2691
Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T (1987) HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327: 426–430
Salgame P, Convit J, Bloom BR (1991) Immunological suppression of human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 88: 2598–2602
Stern LJ, Brown JH, Jardetzky TS et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215–221
Brown JH, Jardetzky TS, Gorga JC et al. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39
Marshall KW, Liu AF, Canales J et al. (1994) Role of polymorphic residues in HLA-DR molecules in allele-specific binding of peptide antigens. J Immunol 152: 4946–4957
Hammer J, Valsasnini P, Tolba K et al. (1993) Promiscuous and allele specific anchors in HLA-DR-binding peptides. Cell 74: 197–203
Kropshofer H, Max H, Halder T, Kalbus M, Muller C, Kalbacher H (1993) Self peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming. J Immunol 151: 4732–4742
Sette A, Sidney J, Oseroff C et al. (1993) HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 151: 3163–3170
Falk K, Rötzsche O, Stefanovic S, Jung G, Rammensee H-G (1994) Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing and general rules. Immunogenetics 39: 230–242
De Vos AM, Ultsch M, Kossiakoff AA (1992) Human growth hormone and the extracellular domain of its receptor: crystal structure of the complex. Science 255: 306–312
Paliakasis K, Routsias J, Petratos K, Ouzounis C, Kokkinidis M, Papadopoulos GK (1994) Modelling of the structure of the human histocompatibility molecules HLA-DQ based on the published structure of HLA-DR1. 13th International Immunology and Diabetes Workshop, Montvillagerne, France, May 25–28, 1994 (Abstract)
Srinivasan N, Blundell TL (1993) An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. Prot Engineering 6: 501–510
Johnson MS, Srinivasan N, Sowdhamini R, Blundell T (1994) Knowledge-based protein modeling. Crit Rev Biochem Mol Biol 29: 1–68
Weber IT (1991) Modeling of structure of Human Immunodeficiency Virus-1 protease with substrate based on crystal structure of Rous Sarcoma Virus protease. Methods Enzymol 202: 727–741
Marsh SGE, Bodmer J (1991) HLA Class II nucleotide sequences. Tissue Antigens 37: 181–189
Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC (1988) A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules. Nature 332: 845–850
O'Shea EK, Klemm JD, Kim PS, Alber T (1991) X-ray structure of the GCN4 leucine zipper, a two-stranded parallel coiled coil. Science 254: 539–544
Konig R, Huang Y-L, Germain RN (1992) MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356: 796–798
Cammarota G, Scheirle A, Tacaks B et al. (1992) Identification of a CD4 binding site on the Β2 domain of HLA-DR molecules. Nature 356: 799–801
Sanjeevi CB, Lybrand TP, DeWesee C et al. (1995) Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Diabetes 44: 125–131
Lernmark å (1994) Molecular biology of IDDM. Diabetologia 37[Suppl 2]: S73-S81
Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238: 491–497
Huang T-F, Holt JC, Kirby EP, Niewiarowski S (1989) Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex in human platelets. Biochemistry 28: 661–666
Leahey DJ, Hendrickson WA, Aukhil I, Erickson HP (1992) Structure of fibronectin type II domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science 258: 987–991
Hynes RO (1992) Integrins: versality, modulation and signaling in cell adhesion. Cell 69: 11–25
Springer TA (1994) Traffic signals for leukocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–312
Janossy G, Thomas JA, Bollum FJ et al. (1980). The human thymic microenvironment: an immunohistochemical study. J Immunol 125: 202–212
Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17–27
Swat W, Ignatowicz L, von Boehmer H, Kisielow P (1991) Clonal deletion of immature CD4+ 8+ thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351: 150–153
Todd JA (1994) The emperor's new genes: 1993 RD Lawrence lecture. Diabet Med 11: 6–20
Corr M, Boyd LF, Padlan EA, Margulies DH (1993) H-2Dd exploits a four residue peptide binding motif. J Exp Med 178: 1877–1892
Kaufman DL, Clare-Salzer M, Tian J et al. (1993) Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature 366: 69–72
Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72–75
Baekkeskov S, Aanstoot H-J, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 345: 151–156
Wade WF, Davoust J, Salamero J, Pascale A, Watts TH, Cambier JC (1993) Structural compartmentalization of MHC class II signaling function. Immunol Today 14: 539–546
Michelsen B, Lernmark å (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152
Andersen LC, Beaty JS, Nettles JW, Seyfried CE, Nepom GT, Nepom BS (1991) Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes. J Exp Med 215: 181–192
Morzycka-Wroblewska E, Harwood JI, Smith JR, Kagnoff MS (1993) Structure and evolution of the promoter regions of the DQA genes. Immunogenetics 37: 364–372
Ollerup J, Hillert J, Frederickson J et al. (1989) Primarily chronic-progressive and relapsing-remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 86: 7113–7117
Sollid LM, Marcussen G, Ek G et al. (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ α/Β heterodimer. J Exp Med 169: 345–350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Routsias, J., Papadopoulos, G.K. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM. Diabetologia 38, 1251–1261 (1995). https://doi.org/10.1007/BF00401756
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401756